GEA
CHE icon

Glen Eagle Advisors’s Chemed CHE Stock Holding History

Glen Eagle Advisors’s Portfolio CHE Stock Details CHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.4K Sell
59
-6
-9% -$2.52K ﹤0.01% 553
2026
Q1 		$24.5K Sell
65
-96
-60% -$41.1K ﹤0.01% 539
2025
Q4 		$69K Sell
161
-319
-66% -$139K 0.01% 387
2025
Q3 		$215K Sell
480
-167
-26% -$75.6K 0.03% 254
2025
Q2 		$315K Sell
647
-7
-1% -$3.99K 0.05% 204
2025
Q1 		$403K Buy
654
+185
+39% +$105K 0.07% 165
2024
Q4 		$249K Sell
469
-17
-3% -$9.58K 0.04% 221
2024
Q3 		$292K Buy
486
+178
+58% +$101K 0.05% 207
2024
Q2 		$167K Buy
+308
New +$176K 0.03% 253

Other funds holding CHE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Glen Eagle Advisors's CHE Position: Q2 2026 in Review

Glen Eagle Advisors reduced its Chemed (CHE) stake by 9.2% in Q2 2026, selling an estimated $2.52K and leaving 59 shares worth $27.4K. The position accounts for ﹤0.01% of the portfolio, ranked #553.

Glen Eagle Advisors first reported a position in CHE in Q2 2024 and has held it in 9 quarters since. The position peaked at $403K in Q1 2025. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Glen Eagle Advisors held 59 shares of Chemed worth $27.4K as of Q2 2026.
  • Glen Eagle Advisors sold 6 Chemed shares in Q2 2026, an estimated $2.52K.
  • Chemed made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q2 2026, its #553 holding.
  • Glen Eagle Advisors first reported a position in Chemed in Q2 2024 and has held it in 9 quarters since.
  • Glen Eagle Advisors's Chemed position peaked at $403K in Q1 2025.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.